Amalgamated Bank Incyte Corp Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Incyte Corp stock. As of the latest transaction made, Amalgamated Bank holds 31,585 shares of INCY stock, worth $2.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
31,585
Previous 38,018 16.92%
Holding current value
$2.31 Million
Previous $2.31 Million 9.41%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$57.33 - $68.61 $368,803 - $441,368
-6,433 Reduced 16.92%
31,585 $2.09 Million
Q2 2024

Aug 12, 2024
SELL
$51.18 - $63.75 $95,808 - $119,340
-1,872 Reduced 4.69%
38,018 $2.31 Million
Q1 2024

Apr 23, 2024
SELL
$56.55 - $66.59 $337,886 - $397,875
-5,975 Reduced 13.03%
39,890 $2.27 Million
Q4 2023

Feb 06, 2024
SELL
$52.16 - $64.19 $106,928 - $131,589
-2,050 Reduced 4.28%
45,865 $2.88 Million
Q3 2023

Nov 08, 2023
SELL
$57.77 - $65.93 $30,560 - $34,876
-529 Reduced 1.09%
47,915 $2.77 Million
Q2 2023

Aug 11, 2023
SELL
$60.95 - $75.51 $258,428 - $320,162
-4,240 Reduced 8.05%
48,444 $3.02 Million
Q1 2023

May 02, 2023
BUY
$70.23 - $86.01 $211,462 - $258,976
3,011 Added 6.06%
52,684 $3.81 Million
Q4 2022

Feb 10, 2023
SELL
$67.18 - $84.11 $1,343 - $1,682
-20 Reduced 0.04%
49,673 $3.99 Million
Q3 2022

Nov 09, 2022
SELL
$66.18 - $82.86 $19,655 - $24,609
-297 Reduced 0.59%
49,693 $3.31 Million
Q2 2022

Aug 15, 2022
BUY
$66.18 - $83.18 $62,473 - $78,521
944 Added 1.92%
49,990 $3.8 Million
Q1 2022

Jun 30, 2022
BUY
$66.02 - $79.71 $89,127 - $107,608
1,350 Added 2.83%
49,046 $3.9 Million
Q4 2021

Feb 15, 2022
BUY
$63.34 - $74.11 $301,245 - $352,467
4,756 Added 11.08%
47,696 $3.5 Million
Q3 2021

Oct 29, 2021
SELL
$68.67 - $84.02 $117,425 - $143,674
-1,710 Reduced 3.83%
42,940 $2.95 Million
Q2 2021

Aug 16, 2021
BUY
$79.87 - $87.53 $2.66 Million - $2.92 Million
33,314 Added 293.88%
44,650 $3.76 Million
Q1 2021

May 13, 2021
SELL
$76.02 - $100.5 $33,144 - $43,818
-436 Reduced 3.7%
11,336 $921,000
Q4 2020

Feb 12, 2021
SELL
$80.74 - $97.7 $4,440 - $5,373
-55 Reduced 0.47%
11,772 $0
Q3 2020

Oct 30, 2020
SELL
$85.07 - $109.69 $25,265 - $32,577
-297 Reduced 2.45%
11,827 $1.06 Million
Q2 2020

Aug 10, 2020
SELL
$74.18 - $108.93 $1.31 Million - $1.92 Million
-17,644 Reduced 59.27%
12,124 $1.26 Million
Q1 2020

May 13, 2020
SELL
$63.18 - $85.97 $55,851 - $75,997
-884 Reduced 2.88%
29,768 $2.18 Million
Q4 2019

Feb 13, 2020
BUY
$73.04 - $95.72 $102,329 - $134,103
1,401 Added 4.79%
30,652 $2.68 Million
Q3 2019

Nov 13, 2019
BUY
$72.82 - $86.52 $417,112 - $495,586
5,728 Added 24.35%
29,251 $2.17 Million
Q2 2019

Aug 14, 2019
SELL
$73.52 - $88.7 $207,988 - $250,932
-2,829 Reduced 10.74%
23,523 $2 Million
Q1 2019

May 15, 2019
BUY
$63.56 - $88.17 $34,258 - $47,523
539 Added 2.09%
26,352 $2.27 Million
Q4 2018

Feb 15, 2019
SELL
$58.5 - $69.94 $41,535 - $49,657
-710 Reduced 2.68%
25,813 $1.64 Million
Q3 2018

Nov 14, 2018
SELL
$61.75 - $74.23 $52,734 - $63,392
-854 Reduced 3.12%
26,523 $1.83 Million
Q2 2018

Jul 18, 2018
BUY
$60.85 - $83.98 $117,318 - $161,913
1,928 Added 7.58%
27,377 $1.83 Million
Q1 2018

May 22, 2018
BUY
$83.06 - $100.98 $207,483 - $252,248
2,498 Added 10.88%
25,449 $2.12 Million
Q4 2017

Feb 13, 2018
BUY
$93.56 - $116.6 $245,033 - $305,375
2,619 Added 12.88%
22,951 $2.17 Million
Q3 2017

Nov 09, 2017
BUY
$109.15 - $138.27 $2.22 Million - $2.81 Million
20,332
20,332 $2.37 Million

Others Institutions Holding INCY

# of Institutions
645
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email